Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Tetraploidy constitutes an adaptation to stress and an intermediate step between euploidy and aneuploidy in oncogenesis. Tetraploid cells are particularly resistant against genotoxic stress including radiotherapy and chemotherapy. Here, we designed a strategy to preferentially kill tetraploid tumor cells. Depletion of checkpoint kinase-1 (Chk1) by siRNAs, transfection with dominant-negative Chk1 mutants or pharmacological Chk1 inhibition killed tetraploid colon cancer cells yet had minor effects on their diploid counterparts. Chk1 inhibition abolished the spindle assembly checkpoint and caused premature and abnormal mitoses that led to p53 activation and cell death at a higher frequency in tetraploid than in diploid cells. Similarly, abolition of the spindle checkpoint by knockdown of Bub1, BubR1 or Mad2 induced p53-dependent apoptosis of tetraploid cells. Chk1 inhibition reversed the cisplatin resistance of tetraploid cells in vitro and in vivo, in xenografted human cancers. Chk1 inhibition activated p53-regulated transcripts including Puma/BBC3 in tetraploid but not in diploid tumor cells. Altogether, our results demonstrate that, in tetraploid tumor cells, the inhibition of Chk1 sequentially triggers aberrant mitosis, p53 activation and Puma/BBC3-dependent mitochondrial apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Of note, the primary alterations that drive catastrophic mitoses can originate in other phases of the cell cycles, including the S phase (e.g., a premature entry in mitosis caused by failure of the intra-S-phase checkpoint) [979, 980].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [980]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · cited 1×
“As a control, a siRNA specific for emerin [56] as well as unrelated control siRNAs (scramble, SCR) were used.”
MethodCalreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216 · cited 1×
“c in 200 ml of PBS with 3610(6) diploid or tetraploid HCT116 cells into the lower flank as previously described [60].”
MethodSelf-citationDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · cited 2×
“activation of Chk2 helps in the elimination of potentially malignant cells [18,19], and that familial loss-of-function muta-”
BackgroundDNA methylation and epigenetic inheritance
Holliday, R. (1990) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1990.0015 · Cited by 2,279
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009 · cited 2×
“activation of Chk2 helps in the elimination of potentially malignant cells [18,19], and that familial loss-of-function muta-”
BackgroundCell death by mitotic catastrophe: a molecular definition
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269 · cited 1×
“activation of pro-apoptotic genes that cause the elimination of the tetraploid cell by programmed cell death [7,8,12,13].”
BackgroundSelf-citationATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1
Zhao, H., & Piwnica-Worms, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4129-4139.2001 · Cited by 1,091 · cited 1×
“The DNA damage-elicited kinase ATR is elicited by cisplatin [48,49] and may participate in the activation of Chk1, which in turn mediates the cisplatin-induced cell cycle arrest [50,51].”
BackgroundCytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells
Fujiwara, T., Bandi, M., Nitta, M., Ivanova, E. V., Bronson, R. T., & Pellman, D. (2005) · Nature · doi:10.1038/nature04217 · Cited by 1,067 · cited 1×
“Experimental tetraploidization of p53-negative mammary epithelial cells can be employed as a method to generate transformed, tumorigenic cells, thus providing a proof-of-principle that tetraploidization may constitute an important intermediate step in carcinogenesis [5].”
BackgroundShieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C. (2000) · Genes & Development · doi:10.1101/gad.14.3.289 · Cited by 972 · cited 1×
“First, Chk1 activation reportedly causes the phosphorylation of p53, resulting in its stabilization and its transcriptional activation [37].”
BackgroundFrom polyploidy to aneuploidy, genome instability and cancer
Storchova, Z., & Pellman, D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1276 · Cited by 810 · cited 1×
“. Tetraploid cells then can undergo asymmetric cell division and/or chromosome loss, leading to aneuploidization and chromosomal instability”
BackgroundUncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature · doi:10.1038/381713a0 · Cited by 728 · cited 1×
“proteins p21 [14], Bax [8], APC [15], or Lats2 [12] facilitates the generation of tetraploid cells.”
BackgroundReinhardt, H. C., Aslanian, A. S., Lees, J. A., & Yaffe, M. B. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.024 · Cited by 596 · cited 1×
“The DNA damage-elicited kinase ATR is elicited by cisplatin [48,49] and may participate in the activation of Chk1, which in turn mediates the cisplatin-induced cell cycle arrest [50,51].”
BackgroundLysosomal Membrane Permeabilization Induces Cell Death in a Mitochondrion-dependent Fashion
Boya, P., Andreau, K., Poncet, D., Zamzami, N., Perfettini, J.-L., Metivier, D., Ojcius, D. M., Jäättelä, M., & Kroemer, G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021952 · Cited by 483 · cited 1×
“, or a p53-inducible green fluorescence protein (GFP) plasmid (gift from K. Wiman, Karolinska Cancer Center, Stockolm, Sweden)”
BackgroundSelf-citationHeselmeyer, K., Schröck, E., du Manoir, S., Blegen, H., Shah, K., Steinbeck, R., Auer, G., & Ried, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.479 · Cited by 468 · cited 1×
“Accordingly, pre-malignant and malignant tetraploid cells have been documented in precancerous lesions such as Barret’s esophagus [27], in pre-invasive lesions of the uterine cervix [17,28], in laryngeal dysplasia [29], and in chronic ulcerative colitis dysplasia [30].”
BackgroundTetraploid State Induces p53-dependent Arrest of Nontransformed Mammalian Cells in G1
Andreassen, P. R., Lohez, O. D., Lacroix, F. B., & Margolis, R. L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1315 · Cited by 428 · cited 1×
“One possible interpretation of these findings is that a hypothetical ‘‘tetraploidy checkpoint’’ [9] would prevent the generation or propagation of tetraploid cells, by”
BackgroundChromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines
Shi, Q., & King, R. W. (2005) · Nature · doi:10.1038/nature03958 · Cited by 394 · cited 1×
“tosis (karyokinesis without cytokinesis) [1] or aberrant cell fusion”
BackgroundChk2 activates E2F-1 in response to DNA damage
Stevens, C., Smith, L., & La Thangue, N. B. (2003) · Nature Cell Biology · doi:10.1038/ncb974 · Cited by 385 · cited 9×
“Aliquots of protein extracts (50 mg/lane) were subjected to immunoblots using antibodies specific for Bcl-2 (Santa Cruz Biotechnology), Bub1 (Chemicon International), CENP-B (Santa Cruz Biotechnology), BubR1 (BD Biosciences), Chk1 (Santa Cruz Biotechnology), Chk2 (Upstate), Mad2 (Santa Cruz Biotechnology), VDAC (anti-…”
BackgroundInfluentialBiological implications of cell fusion
Ogle, B. M., Cascalho, M., & Platt, J. L. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1678 · Cited by 343
Gatei, M., Sloper, K., Sörensen, C., Syljuäsen, R., Falck, J., Hobson, K., Savage, K., Lukas, J., Zhou, B.-B., Bartek, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210862200 · Cited by 300 · cited 1×
“. Alternatively, cells were transfected with CMV-driven expression plasmids containing WT or DN Chk1 (kinase dead, gift by K.K. Khanna)”
MethodDuelli, D., & Lazebnik, Y. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00114-4 · Cited by 291
A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization
Aylon, Y., Michael, D., Shmueli, A., Yabuta, N., Nojima, H., & Oren, M. (2006) · Genes & Development · doi:10.1101/gad.1447006 · Cited by 284 · cited 3×
“Similarly, the loss of the tumor suppressor proteins p21 [14], Bax [8], APC [15], or Lats2 [12] facilitates the generation of tetraploid cells.”
BackgroundHypoxia and defective apoptosis drive genomic instability and tumorigenesis
Nelson, D. A., Tan, T.-T., Rabson, A. B., Anderson, D., Degenhardt, K., & White, E. (2004) · Genes & Development · doi:10.1101/gad.1204904 · Cited by 281 · cited 1×
“Since polyploid tumor cells accumulate in particular areas of the cancerous lesion, for instance in areas of hypoxia [34], it can be speculated that tetraploid cells might contribute to chemotherapeutic failure.”
BackgroundWang, X., Zhou, Y.-X., Qiao, W., Tominaga, Y., Ouchi, M., Ouchi, T., & Deng, C.-X. (2006) · Oncogene · doi:10.1038/sj.onc.1209707 · Cited by 261 · cited 1×
“Symmetrically, overexpression of oncogene products such as Aurora kinase A [16] or papillomavirus E6 [17] induces tetraploidization.”
BackgroundChk1 Is Required for Spindle Checkpoint Function
Zachos, G., Black, E. J., Walker, M., Scott, M. T., Vagnarelli, P., Earnshaw, W. C., & Gillespie, D. A. F. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.01.003 · Cited by 236 · cited 2×
“Chk1 is required for spindle checkpoint function, both in normal and in taxol-treated cells [45].”
BackgroundMethods for the assessment of mitochondrial membrane permeabilization in apoptosis
Galluzzi, L., Zamzami, N., de La Motte Rouge, T., Lemaire, C., Brenner, C., & Kroemer, G. (2007) · Apoptosis · doi:10.1007/s10495-007-0720-1 · Cited by 224 · cited 1×
“, and propidium iodide (PI, 2 µg/ml, Sigma-Aldrich) or 4′,6-diamidino-2-phenylindole (DAPI, 10 µM, Molecular Probes-Invitrogen), vital dyes that incorporate only into dead cells), for 30 min at 37°C”
BackgroundSelf-citationTighe, A., Johnson, V. L., & Taylor, S. S. (2004) · Journal of Cell Science · doi:10.1242/jcs.01556 · Cited by 222 · cited 2×
“Similarly, the loss of the tumor suppressor proteins p21 [14], Bax [8], APC [15], or Lats2 [12] facilitates the generation of tetraploid cells.”
BackgroundThe CHEK2 gene and inherited breast cancer susceptibility
Nevanlinna, H., & Bartek, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209877 · Cited by 219 · cited 2×
“The checkpoint kinase-1 (Chk1) is also lost in aggressive lymphoid tumors [20].”
BackgroundApoptosis regulation in tetraploid cancer cells
Castedo, M., Coquelle, A., Vivet, S., Vitale, I., Kauffmann, A., Dessen, P., Pequignot, M. O., Casares, N., Valent, A., Mouhamad, S., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601127 · Cited by 206 · cited 20×
“The polyclonal rabbit antibodies specific for Puma, ATF3 and Bax were from Y ProSci Incorporated, Santa Cruz Biotechnology, and Upstate Biotechnology, respectively.”
BackgroundMethodSelf-citationRecurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region
Van Dyke, D. L., Worsham, M. J., Drumheller, T., Benninger, M. S., Krause, C. J., Baker, S. R., Wolf, G. T., Carey, T. E., & Tilley, B. C. (1994) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870090308 · Cited by 203 · cited 1×
“prognosis, for instance in uterine cervix carcinoma [31], squamous cell carcinoma of the head and neck [32], and in poorly differentiated prostate carcinoma [33].”
BackgroundMaley, C. C., Galipeau, P. C., Li, X., Sanchez, C. A., Paulson, T. G., Blount, P. L., & Reid, B. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1738 · Cited by 193 · cited 1×
“Accordingly, pre-malignant and malignant tetraploid cells have been documented in precancerous lesions such as Barret’s esophagus [27], in pre-invasive lesions of the uterine cervix [17,28], in laryngeal dysplasia [29], and in chronic ulcerative colitis dysplasia [30].”
BackgroundPetermann, E., Maya-Mendoza, A., Zachos, G., Gillespie, D. A. F., Jackson, D. A., & Caldecott, K. W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3319-3326.2006 · Cited by 181
Mechanisms of apoptosis induction by the HIV-1 envelope
Perfettini, J.-L., Castedo, M., Roumier, T., Andreau, K., Nardacci, R., Piacentini, M., & Kroemer, G. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401584 · Cited by 169 · cited 5×
“) or with mouse antisera specific for cytochrome c (cyt c, BD Biosciences, San Jose, USA), b-tubulin, or c-tubulin (both from Sigma-Aldrich) [7,59].”
BackgroundSelf-citationSequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelope
Castedo, M., Roumier, T., Blanco, J., Ferri, K. F., Barretina, J., Tintignac, L. A. J., Andréau, K., Perfettini, J., Amendola, A., Nardacci, R., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf391 · Cited by 165 · cited 7×
“) or with mouse antisera specific for cytochrome c (cyt c, BD Biosciences, San Jose, USA), b-tubulin, or c-tubulin (both from Sigma-Aldrich) [7,59].”
BackgroundSelf-citationTumour-cell fusion as a source of myeloid traits in cancer
Pawelek, J. M. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70466-6 · Cited by 164 · cited 2×
“Tetraploid cells are intrinsically resistant against genotoxic stress mediated by ionizing irradiation or by genotoxic agents used for anti-cancer chemotherapy, including platinum compounds (such as cisplatin and oxaliplatin) and topoisomerase inhibitors (such as camptothecin) [8,25], meaning that tetraploid cells hav…”
BackgroundSampath, D. (2006) · Blood · doi:10.1182/blood-2005-08-3351 · Cited by 152 · cited 1×
“Chk1 inhibitors including UCN-01 are being introduced into clinical trials [24] in combination with genotoxic agents such as cytarabine (for the treatment of acute myeloid leukemia) [46] or cisplatin (for the treatment of advanced solid tumors) [47], and proof has been obtained that UCN-01 can actually inhibit Chk1 in…”
BackgroundDepletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites
Durkin, S. G., Arlt, M. F., Howlett, N. G., & Glover, T. W. (2006) · Oncogene · doi:10.1038/sj.onc.1209466 · Cited by 151 · cited 1×
“for optimal progression of replication forks during normal S phase of vertebrate cells [41] and avoids the accumulation of DNA breaks at fragile sites [42].”
BackgroundDepletion of Chk1 Leads to Premature Activation of Cdc2-cyclin B and Mitotic Catastrophe
Niida, H., Tsuge, S., Katsuno, Y., Konishi, A., Takeda, N., & Nakanishi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505009200 · Cited by 137 · cited 1×
“Chk1 depletion can favor the premature activation of the Cdk1/ cyclin B1 complex [43], before the completion of the S phase, which leads to mitotic defects with chromosome misalignment during metaphase, chromosome lagging during anaphase, and kinetochore defects within the regions of misaligned/lagging chromosomes [44…”
BackgroundSelective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics
Chen, Z., Xiao, Z., Gu, W., Xue, J., Bui, M. H., Kovar, P., Li, G., Wang, G., Tao, Z., Tong, Y., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22198 · Cited by 130
Tang, J., Erikson, R. L., & Liu, X. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604987103 · Cited by 128 · cited 1×
“Chk1 depletion can favor the premature activation of the Cdk1/ cyclin B1 complex [43], before the completion of the S phase, which leads to mitotic defects with chromosome misalignment during metaphase, chromosome lagging during anaphase, and kinetochore defects within the regions of misaligned/lagging chromosomes [44…”
BackgroundTetraploidy and tumor development
Margolis, R. L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.017 · Cited by 109
Nonapoptotic Role for Apaf-1 in the DNA Damage Checkpoint
Zermati, Y., Mouhamad, S., Stergiou, L., Besse, B., Galluzzi, L., Boehrer, S., Pauleau, A., Rosselli, F., D’Amelio, M., Amendola, R., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.030 · Cited by 109
Self-citationLara, P. N., Mack, P. C., Synold, T. W., Frankel, P. H., Longmate, J., Gumerlock, P. H., Doroshow, J. H., & Gandara, D. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2602 · Cited by 100 · cited 1×
“or cisplatin (for the treatment of advanced solid tumors)”
BackgroundSyljuåsen, R. G., Sørensen, C. S., Nylandsted, J., Lukas, C., Lukas, J., & Bartek, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2434 · Cited by 99
Mitochondrial control of cell death induced by hyperosmotic stress
Criollo, A., Galluzzi, L., Chiara Maiuri, M., Tasdemir, E., Lavandero, S., & Kroemer, G. (2007) · Apoptosis · doi:10.1007/s10495-006-0328-x · Cited by 96 · cited 1×
“Cells were cultured in 12-well plates and transfected at 30–40% confluence by adding HiPerFect (Qiagen, Hilden, Germany) complexed with siRNA (final concentration: 20nM) as described previously [57].”
MethodSelf-citationChk1 Inhibitors for Novel Cancer Treatment
Tao, Z., & Lin, N. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006777698132 · Cited by 95 · cited 1×
“Chk1 inhibitors including UCN-01 are being introduced into clinical trials [24] in combination with genotoxic agents such as cytarabine (for the treatment of acute myeloid leukemia) [46] or cisplatin (for the treatment of advanced solid tumors) [47], and proof has been obtained that UCN-01 can actually inhibit Chk1 in…”
BackgroundA primate virus generates transformed human cells by fusion
Duelli, D. M., Hearn, S., Myers, M. P., & Lazebnik, Y. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507069 · Cited by 95 · cited 1×
“A fusogenic retrovirus can induce the transformation of human cells in vitro through cell fusion [26].”
BackgroundIncassati, A., Patel, D., & McCance, D. J. (2005) · Oncogene · doi:10.1038/sj.onc.1209276 · Cited by 92
Tse, A. N., & Schwartz, G. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0841 · Cited by 92 · cited 1×
“. On the contrary, here we show that the inhibition of Chk1 can activate p53, as indicated by an increased p53 phosphorylation and an increased transcription of p53 target genes. Second, Chk1 inhibition by UCN-01 or other chemical Chk1 inhibitors has been shown to sensitize preferentially p53-deficient cells”
BackgroundCisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation
Damia, G., Filiberti, L., Vikhanskaya, F., Carrassa, L., Taya, Y., Dincalci, M., & Broggini, M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900122 · Cited by 92
Asher, G., Lotem, J., Tsvetkov, P., Reiss, V., Sachs, L., & Shaul, Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436329100 · Cited by 70 · cited 1×
“Soussi, Institut Curie, Paris, France) under the control of the cytomegalovirus (CMV) promoter [52].”
BackgroundSelective Resistance of Tetraploid Cancer Cells against DNA Damage‐Induced Apoptosis
CASTEDO, M., COQUELLE, A., VITALE, I., VIVET, S., MOUHAMAD, S., VIAUD, S., ZITVOGEL, L., & KROEMER, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.004 · Cited by 67 · cited 3×
“We used Agilent long (60bp) oligonucleotide microarrays and the dual color analysis method in which probes from specimens and from the reference are differentially labeled with Cyanine 5 and Cyanine 3 as described previously (Castedo et al, 2006).”
BackgroundMethodSelf-citationLevesque, A. A., Kohn, E. A., Bresnick, E., & Eastman, A. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208451 · Cited by 65
Ckap2 Regulates Aneuploidy, Cell Cycling, and Cell Death in a p53-Dependent Manner
Tsuchihara, K., Lapin, V., Bakal, C., Okada, H., Brown, L., Hirota-Tsuchihara, M., Zaugg, K., Ho, A., Itie-YouTen, A., Harris-Brandts, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4223 · Cited by 47
Furuta, T., Hayward, R. L., Meng, L.-H., Takemura, H., Aune, G. J., Bonner, W. M., Aladjem, M. I., Kohn, K. W., & Pommier, Y. G. (2006) · Oncogene · doi:10.1038/sj.onc.1209313 · Cited by 45
Guerra, S., López-Fernández, L. A., García, M. A., Zaballos, A., & Esteban, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511983200 · Cited by 40 · cited 1×
“). Knockdown of the BH3-only protein Puma/BBC3, of the Bcl-2 antagonist Bax, or of the pro-apoptotic transcription factor ATF3”
BackgroundDrug discovery targeting Chk1 and Chk2 kinases.
Zhou, B. S., & Sausville, E. A. (2003) · PubMed · Cited by 36
Hzf, a p53-Responsive Gene, Regulates Maintenance of the G2 Phase Checkpoint Induced by DNA Damage
Sugimoto, M., Gromley, A., & Sherr, C. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.502-512.2006 · Cited by 35
The DNA content in cancer and dysplasia in chronic ulcerative colitis
Cuvelier, C. A., Morson, B. C., & Roels, H. (1987) · Histopathology · doi:10.1111/j.1365-2559.1987.tb01899.x · Cited by 29 · cited 1×
“Accordingly, pre-malignant and malignant tetraploid cells have been documented in precancerous lesions such as Barret’s esophagus [27], in pre-invasive lesions of the uterine cervix [17,28], in laryngeal dysplasia [29], and in chronic ulcerative colitis dysplasia [30].”
BackgroundBjelkenkrantz, K., Lundgren, J., & Olofsson, J. (1983) · PubMed · Cited by 16
Dr, B., Duhr, M. A., & Ya, B. (1985) · PubMed · Cited by 11
DNA cytometry in diagnostic cytology of the prostate gland.
Buhmeida, A. S., BÄCKMAN, H., & Collan, Y. U. (2002) · PubMed · Cited by 10
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
“, a premature entry in mitosis caused by failure of the intra-S-phase checkpoint) [979, 980].”
BackgroundSelf-citationMolecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
“This phenomenon can be reverted by the depletion/inhibition of TP53, its target ribonucleotide reductase M2 B (RRM2B) or CHEK1 (Castedo et al., 2006; Vitale et al., 2007), implying that the cisplatinresistant phenotype of tetraploid cancer cells relies on complex mechanisms that go beyond a merely…”
BackgroundInfluentialSelf-citationDissecting the genomic complexity underlying medulloblastoma
Jones, D. T. W., Jäger, N., Kool, M., Zichner, T., Hutter, B., Sultan, M., Cho, Y.-J., Pugh, T. J., Hovestadt, V., Stütz, A. M., et al. (2012) · Nature · doi:10.1038/nature11284 · Cited by 839
Mitotic catastrophe: a mechanism for avoiding genomic instability
Vitale, I., Galluzzi, L., Castedo, M., & Kroemer, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3115 · Cited by 834
“This can directly stimulate the mitotic death programme of mitotic catastrophe or lead to the generation of multinucleated (mostly binucleated) tetraploid cells, which are intrinsically more prone to mitotic aberrations (and hence to mitotic catastrophe) than their diploid counterpart”
BackgroundSelf-citationSystems biology of cisplatin resistance: past, present and future
Galluzzi, L., Vitale, I., Michels, J., Brenner, C., Szabadkai, G., Harel-Bellan, A., Castedo, M., & Kroemer, G. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.428 · Cited by 782
Self-citation
Metadata
- Authors
- Vitale, I., Galluzzi, L., Vivet, S., Nanty, L., Dessen, P., Senovilla, L., Olaussen, K. A., Lazar, V., Prudhomme, M., Golsteyn, R. M., Castedo, M., & Kroemer, G.
- Affiliations
- Université Paris-Sud (FR)
- Inserm (FR)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Kroemer, Guido
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-12-26
- Volume
- 2
- Issue
- 12
- Pages
- e1337
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2131784
- OpenAlex
- W1978860052
- Cited by
- 77
- References
- 62
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 3 · 2021: 5 · 2020: 5 · 2019: 2 · 2018: 6 · 2017: 4 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 6 · 2012: 10
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Association pour la Recherche sur le Cancer
- Institut National Du Cancer
- Institut Gustave-Roussy
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- tetraploidy, CHK1 inhibition, p53 activation, spindle assembly checkpoint, aberrant mitosis, mitochondrial apoptosis, cisplatin resistance, colon cancer, BUB1, BubR1, Mad2, genotoxic stress resistance, tumor cell killing
- MeSH terms
- Checkpoint Kinase 1, Cisplatin, Humans, Spindle Apparatus, Polyploidy, Protein Kinases, Signal Transduction, Tumor Suppressor Protein p53, Apoptosis, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.